The story of Sildenafil presents a complex picture for those considering investment. While the initial release generated significant gains, the end of its exclusive rights opened the floodgates to cheaper competitors, https://bookmarkproduct.com/story21755224/sildenafil-and-pharma-a-precarious-opportunity